Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000328813 | SCV000338448 | pathogenic | not provided | 2016-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003619668 | SCV004525978 | pathogenic | DNA ligase IV deficiency | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile584Argfs*2) in the LIG4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 328 amino acid(s) of the LIG4 protein. This variant is present in population databases (rs770128720, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with LIG4-related conditions (PMID: 25239263). ClinVar contains an entry for this variant (Variation ID: 285436). This variant disrupts a region of the LIG4 protein in which other variant(s) (p.Arg814*) have been determined to be pathogenic (PMID: 11779494, 16088910, 24123394, 25239263, 27063650, 27612988). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |